"Nanomedicine and nano-biotechnology are two rapidly emerging interdisciplinary areas.There are many challenges for these paradigm-changing fields,especially in the area of scientific communication.Ways and means of communication is rapidly changing and publishing is also undergoing dynamic changes.While researchers are under tremendous pressure to prove themselves by publishing “novel,significant,and original” papers in “highimpact” journals,publishers have to run successful businesses.The essential question for editors and researchers is how to determine value of research and identify value in published science.This discussion is now expanding and several articles have recently appeared in well-known journals(Science,Nature,The Economist,etc.)questioning the value and methods of science including translation of publications into products.Getting published is crucial for academicians and researchers.In this talk the speaker will summarize major changes in business models(traditional,open access,and hybrid),describe the use and abuse of Impact Factor,and introduce the latest scientific methods used for determining the value of journals.Examples will be provided to explain how these tools may be used correctly to evaluate publication activities of individual authors,groups,institutions,and countries.In addition to comparing leading nanomedicine journals,I will describe the editorial procedure used at Nanomedicine: NBM and a Q&A opportunity will also be provided."